1 / 8

30:1 Adv0

Figure 1. A. B. C. Uninfected 3:1 10:1 30:1 60:1. Uninfected 10:1 30:1 60:1. 30:1 Adv0. 30:1 AdvGFP. Figure 2. Cytosolic I B p42/44 MAP kinases NF B activation on EMSA. Uninf AdvI B Adv0. Figure 3. Adv0. 180. 160. AdvI B. 140. 120. 100. % production.

olympe
Download Presentation

30:1 Adv0

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure 1 A B C Uninfected 3:1 10:1 30:1 60:1 Uninfected 10:1 30:1 60:1 30:1 Adv0 30:1 AdvGFP

  2. Figure 2 Cytosolic IB p42/44 MAP kinases NFB activation on EMSA Uninf AdvIB Adv0

  3. Figure 3 Adv0 180 160 AdvIB 140 120 100 % production 80 60 40 20 0 TNF IL-1 IL-10 Cytokine

  4. Figure 4 Adv0 140 AdvIB 120 100 80 % production 60 40 20 0 IL-6 IL-8 MCP-1 OnST-M GM-CSF Cytokine

  5. IL-11 IL-1 RA p55sTNF-R p75sTNF-R Figure 5 Adv0 120 AdvIB 100 80 % production 60 40 20 0 Cytokine

  6. Figure 6 160 Adv0 140 AdvIB 120 100 % production 80 60 40 20 0 MMP-1 MMP-3 MMP-9 MMP-13 TIMP-1

  7. Figure 7 TNF + Cycloheximide AdvIkBa Treatment AdvO 0 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 Caspase Ratio E A B C D

  8. Figure 8 A B Uninfected Uninfected Adv0 Adv0 AdvIB AdvIB

More Related